Also known as: Strawberry Cheese · SCC

Strawberry Cheesecake

A dessert-named hybrid with several conflicting origin stories and no strain-specific clinical research to back its marketed effects.

Sourced and fact-checked
7 cited sources
Published 2 hours ago
How this page was made
↯ The honest take

Strawberry Cheesecake is a marketing name, not a fixed genetic. At least three different breeders sell something called 'Strawberry Cheesecake,' and the plants behind those labels aren't the same. The 'strawberry' nose is real in some phenotypes but often more Cheese-funk than fruit. Cannabinoid and terpene numbers vary wildly between seed banks and lab tests. Treat any specific claim about effects, THC percentage, or lineage with skepticism unless the exact vendor and a recent COA are attached.

Overview

Strawberry Cheesecake is a dessert-branded hybrid sold by multiple seed banks and dispensaries, most of them claiming a cross involving Cheese and a Strawberry-line parent. It is marketed as a relaxing, sweet-smelling evening strain. There is no standardized genetic behind the name — different vendors sell plants under this label that likely share little more than the branding Disputed. Because of this, generalizations about aroma, potency, and effect should be read as marketing composites, not properties of a single verified cultivar.

Chemistry: cannabinoids and terpenes

Publicly available lab data specific to 'Strawberry Cheesecake' is sparse and inconsistent across sources. Vendor pages typically list THC in the 15–20% range with negligible CBD Weak / limited. Terpene profiles reported by seed banks and consumer databases most often flag myrcene and beta-caryophyllene as dominant, sometimes with limonene Weak / limited.

Broader cannabis chemistry research shows that strain names correlate poorly with chemotype: samples sold under the same name can differ substantially in cannabinoid and terpene content [1][2]. That finding applies to Strawberry Cheesecake at least as strongly as to better-studied names, because there is no single stabilized seed line behind it.

Reported effects

Consumers commonly describe Strawberry Cheesecake as physically relaxing, mildly euphoric, and appetite-stimulating, with a shift toward sedation at higher doses Anecdote. These reports come from vendor pages and crowd-sourced review sites, not controlled studies.

There is no strain-specific clinical research on Strawberry Cheesecake — none for efficacy, none for safety, none for any medical claim. General cannabis research supports that THC-dominant flower can reduce short-term anxiety at low doses and increase it at higher doses [3], can stimulate appetite [4], and can impair short-term memory and coordination during acute intoxication [3]. Attributing any of those effects specifically to this strain rather than to THC and dose is not supported by evidence No data.

Lineage (disputed)

Lineage claims for Strawberry Cheesecake diverge by breeder:

Because the name is not trademarked and clones travel through unofficial channels, two plants sold under this name in different cities are unlikely to share the same pedigree. Treat any confident lineage tree as marketing rather than fact.

Cultivation basics

Reported grow characteristics — again, breeder-dependent — describe a medium-height, branchy plant that finishes in roughly 8–9 weeks indoors and produces moderate yields [evidence:practitioner]. Cheese-derived lines tend to smell strongly during late flower, so odor control is worth planning for. Growers report the strain tolerates typical mistakes reasonably well and does not demand exotic feeding schedules Anecdote.

As with any hybrid sold under a shared name, phenotype variation from seed can be significant. If a specific expression matters to you, source clones from a grower whose plant you have actually smelled and seen finished.

Marketing vs. reality

'It tastes like strawberry cheesecake.' Some phenotypes have a sweet, dairy-fruit note. Many lean much harder into Cheese funk than into fruit. Aroma names are aspirational, not guaranteed Anecdote.

'It's an indica, so it'll couch-lock you.' The indica/sativa label is a poor predictor of effect. Chemotype (cannabinoid and terpene content) and dose matter far more than the category name [1][6]. There is no evidence that 'indica' plants reliably produce more sedation than 'sativa' plants in blinded testing Disputed.

'High-myrcene strains are the sedating ones.' The popular '0.5% myrcene threshold' for sedation is folklore with no controlled human evidence behind it No data. Myrcene has pharmacological activity in animal models, but the threshold number is a repeated claim, not a finding.

'THC around 20% means it's strong.' Labeled THC percentages are frequently inflated relative to independent testing, and the correlation between labeled THC and subjective potency in users is weak [7]. A COA from a reputable lab beats a number printed on a jar.

Sources

How this page was made

Generation history

Jul 24, 2026
Fact-check pass — raised 3 flags
Jul 24, 2026
Initial draft

Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.